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INTRODUCTION:  Mucormycosis  is  a fungal  infection  that  is a rare  cause  of  gastrointestinal  ischemia,  usu-
ally  found  in  the  immunocompromised  or patients  with  extended  surgical  intensive  care  unit  stay.  This
case  report  brings to light  the  rare  presentation  of  a total  gastric  infarction  secondary  to  a  rare  fungal
infection  where  the  overall  outcome  of  the  patient  depends  on  timely  diagnosis  and management.
CASE  PRESENTATION:  An  elderly  Malay female  patient  in  our institution  developed  severe  sepsis.  Radiolog-
ical investigations  revealed  an  intra  abdominal  source  of  sepsis  likely  secondary  to  total  gastric  ischemia.
Both  the  abdominal  X-ray  and  computed  tomography  scan  showed  evidence  of  gastric  pneumotosis.  She
was diagnosed  with  gastric  ischemia  and  underwent  a total  gastrectomy.  However  post  surgically  sheastrointestinal
schemia
astric
neumotosis
continued  to deteriorate  and  passed  away  5 days  later.
CONCLUSION:  Recognition  of mucormycosis  infection  is pertinent  to  commence  anti  fungal  treatment
early  with  timely  implementation  of  subsequent  surgical  management.  Early  access  to  surgery  is neces-
sary  to improve  cure  rates  in  patients  with  mucormycosis  as  antifungal  treatment  alone  is usually  not
adequate  for  cure.
©  2016  The  Authors.  Published  by  Elsevier  Ltd.  on behalf  of IJS  Publishing  Group  Ltd.  This  is an  open
he CCaccess  article  under  t
. Introduction
Anatomical or functional changes in the local vasculature that
ompromise blood ﬂow can lead to ischemia. Common causes of
cclusive obstruction to the blood ﬂow include vascular emboli or
hrombosis and strangulation of the venous blood supply. Primary
planchnic vasoconstriction is the most common cause for non-
cclusive obstruction.
In order for a total infarction, all vasculature feeding the organ
ust be compromised. The stomach is a highly uncommon area for
otal ischemia due to its rich vasculature. In this case report, we
eport a rare cause of vascular compromise to the stomach, which
resented as a diagnostic challenge.
. Case presentation
A 60 year old Malay lady with a signiﬁcant past medical his-
ory of poorly controlled type 2 diabetes mellitus and bone marrow
ransplant for acute myeloid leukemia was admitted for the pre-
enting complain of right otalgia associated with purulent otorrhea.
he was diagnosed with right malignant ottitis externa and started
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on intravenous Augmentin. It was  however found to be refractory
to antibiotic treatment. A follow up computed tomography scan
of the right temporal bone performed 5 days after the commence-
ment of antibiotic therapy showed bony destruction of external
auditory canal, mastoid and right mandibular fossa, associated with
osteomyelitis of the right temporal bone.
Infectious disease consult was  obtained to assist in the
management of her sepsis, and the patient was started on a
planned 6-week intravenous antibiotic therapy of linezolid and
piperacillin/tazobactam. Management included a full septic work
up with blood, urine and pus cultures. However the patient devel-
oped severe sepsis 8 days after the commencement of antibiotic
therapy. It was complicated by metabolic acidosis and acute renal
failure. She was  subsequently intubated and managed in the surgi-
cal intensive care unit.
Cultures performed on pus obtained from the right ear
grew multi-resistant staphylococcus aureus and pseudomonas
aeruginosa. Her urine culture grew Candida albicans. Following the
positive culture results, the antibiotic regime was changed to intra-
venous meropenem and vancomycin. Intravenous caspofungin was
also started for the positive Candida culture results.
During her stay in the surgical intensive care unit, she became
anuric and was started on dialysis, initially on sustained low
efﬁciency dialysis for 2 days before being converted to contin-
uous veno-venous hemodialysis. Patient developed abdominal
distension and an abdominal X-ray was  performed as part of inves-
tigations. It showed mottled lucencies over the gastric lumen,
Group Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. Transverse Computed Tomography Scan Cuts showing extensive intramural
gas affecting the stomach secondary to mucormycosis infection.
Eventually the diagnosis of mucormycosis can be conﬁrmedig. 1. Presence of mottled gas lucencies overlying the gastric lumen is highly sus-
icious for intramural gas secondary to mucormycosis infection.
uspicious of gastric pneumotosis. A computed tomography scan
f the abdomen and pelvis performed conﬁrmed the ﬁndings of
nterval development of extensive gastric intramural gas.
She underwent an exploratory laparotomy and intra-operative
ndings revealed an infarcted stomach from the cardia to the
ylorus. A total gastrectomy was performed. It was noted that
he vasculature of the coeliac axis and the superior mesenteric
rtery had good palpable pulsations. However post operatively, the
atient continued to deteriorate, developing persistent hypoten-
ion and bradycardia despite maximal inotropic support. She
ventually passed away 5 days after the surgery.
The ﬁnal histopathology report of the patient’s total gastrec-
omy specimen reported a total gastric infarction associated with
he presence of widely disseminated fungal organisms. Microscopi-
ally, an infarction of the entire gastric wall was  seen with a “ghost
utline” preservation of architectural features of the main mural
omponents. Stains applied to the specimen showed numerous
ungal organisms disseminated through the entire gastric wall that
as also present within the vascular channels. The fungus consisted
f spores and hyphae of variable irregular sizes, showing branching
t right angles.
. Discussion
Total gastric infarction is a highly unusual presentation as the
tomach is a richly vascular organ. This is due to the multiple vascu-
ar supplies originating from the coeliac axis. Therefore in order to
ave total gastric infarction, most if not all of the vessels supplying
he stomach must be involved. A fungal infection by mucormycosis
s one such rare cause that can involve multiple vessels resulting in
his catastrophic presentation (Fig. 1).
Mucormycosis is a life threatening opportunistic infection
aused by fungi of the subphylum Mucoromycotina, order Muco-
ales. Rhizopus oryzae is the most common organism isolated from
nfected patients [1]. Other genera causing mucormycoses include
ucor,  Lichtheimia, Cunninghamella, Rhizomucor, Saksenaea and
pophysomyces [2].
Risk factors for the development of invasive mycormycosisnclude immunocompromised states such as in diabetes, Acquired
mmunodeﬁciency Syndrome (AIDS), malnutrition, defects in
ost phagocytes, corticosteroid use, and organ or stem cellFig. 3. Coronal cuts showing extensive intramural gas affecting most of the stomach
secondary to mucormycosis infection.
transplantation. However there are also reports of mucormycosis
in patients without any of the above-mentioned risk factors [3].
The fungus produces either superﬁcial or deep mycotic infec-
tions, involving predominantly the skin, nails and external ear.
Gastrointestinal mucormycosis is generally rare, especially in
developed nations. It is seldom diagnosed in living individu-
als. While gastrointestinal infections comprises of only 7% of
the reported cases of mucormycosis, the reported mortality is
around 85%. The stomach is the most common site of gastroin-
testinal mucormycosis, followed by the colon, ileum, duodenum
and jejunum [4–6]. This begets the question of how mucormy-
cosis infection of the gastrointestinal tract occurs. It is commonly
believed that infection of the alimentary tract is due to ingestion
of the spores. The stomach is the ﬁrst major alimentary organ that
comes into contact with the ingested spores, possibly resulting in
it being most commonly infected. In severe cases, infarction of the
infected organ may  occur, as described in our patient. The fungus
has a predilection for the walls of the vessels, both arterial and
venous. The invasion of different types of blood vessels by fungi
hyphae leads to different complications. In arterial invasion, arte-
rial thrombosis can occur and lead to tissue infarction and eventual
necrosis. Venous invasion usually causes hemorrhage [4] (Fig. 2).on either the growth of mold on culture or the histopathological
demonstration on biopsy of aseptate, wide, ribbon-like hyphae that
branches at right angles. However due to the difﬁculty of growing
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aig. 4. Histopathologic examination revealed total gastric infarction associated with
f  mucormycosis within the vascular channels as demonstrated.
he fungal organism from tissue culture, biopsy with histological
dentiﬁcation is usually the preferred mode of diagnosis [7]. The
dvantage of culture is the identiﬁcation and susceptibility test-
ng of the organism. While identiﬁcation and susceptibility testing
llows for a more directed anti-fungal treatment, there is no strong
vidence proving that identiﬁcation is important to guide treat-
ent. It will however allow subsequent epidemiological studies
or this rare fungal infection [8,9].
In event of mucormycosis infection, anti-fungal treatment is
sually inadequate to control mucormycosis. Surgery to debulk
he fungal infection with resection of all the infected necrotic tis-
ue is often required for cure [8]. The inadequacy of anti-fungal
reatment is due to various factors including resistance to the anti-
ungal agents, angioinvasion, thrombosis of vessels resulting in less
ptimal penetration of the medications to the site of interest (Fig. 3).
The European Society for Clinical Microbiology and Infectious
isease and the European Confederation of Medical Mycology has
eleased a joint clinical guideline in the diagnosis and manage-
ent of mucormycosis. It is recommended that in addition to ﬁrst
ine anti fungal treatment with liposomal or lipid complex ampho-
ericin B, surgical debridement be instituted [10] (Fig. 4).
Surgery was found to be an independent variable for favor-
ble outcomes in patients with mucormycosis [7]. It was  found
hat patients who did not undergo surgical intervention had a
igher mortality rate than those who did [11–13]. Reversal of the
redisposing condition is also recommended such as controlling
yperglycaemia in diabetic patients, and limiting the use of glu-
ocorticosteroids or reducing the dosage in immunosuppressed
atients [10].
. Conclusion
Mucormycosis is a rare cause of gastrointestinal ischemia. Its
resentation may  be insidious and an underlying fungal infection
s usually not known until speciﬁc investigations for the present-
ng signs and symptoms of the gastrointestinal ischemia are made.
ven so, by the time the diagnosis of mucormycosis is made, it
ay  be too late for favorable outcomes. Therefore when suspecting
schemic gut in patients, especially in those who are immuno-
ompromised, or one who has had extended surgical intensive
are unit stay, mucormycosis/fungal infections of the gut should
e considered. If mucormycosis is suspected, early consult by the
nfectious disease specialty should be made. This allows appropri-
te anti-fungal treatment to be commenced quickly and the timelyesence of abundant, widely disseminated fungal hyphae with morphologic features
implementation of subsequent surgical management. With better
recognition of mucormycosis as an insidious cause of gastrointesti-
nal ischemia, prompt management may  be instilled to result in
better outcomes.
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